Lilly investors are upbeat on injectable weight-loss treatment Mounjaro, but the pills easier to take, cheaper to make might have the biggest long-term impact.
Lilly investors are upbeat on injectable weight-loss treatment Mounjaro, but the pills easier to take, cheaper to make might have the biggest long-term impact.